September 20, 2007 – The Juvenile Diabetes Research Foundation, the world's largest charitable funder of type 1 diabetes research, announced a partnership with CoMentis, Inc. to support the biotechnology company’s human clinical trial of ATG3, a topical eye drop therapy for diabetic macular edema... CoMentis' Press Release -
Showing posts with label CoMentis. Show all posts
Showing posts with label CoMentis. Show all posts
Friday, September 21, 2007
CoMentis, Diabetic Macular Edema Clinical Trial with JDRF
September 20, 2007 – The Juvenile Diabetes Research Foundation, the world's largest charitable funder of type 1 diabetes research, announced a partnership with CoMentis, Inc. to support the biotechnology company’s human clinical trial of ATG3, a topical eye drop therapy for diabetic macular edema... CoMentis' Press Release -
Subscribe to:
Posts (Atom)
